As women approach menopause, they often encounter a range of physical and emotional symptoms that can negatively impact their quality of life. Hormone Replacement Therapy (HRT), or Menopausal Hormone Therapy (MHT), refers to medical management of these symptoms using supplemental estrogen plus or minus progesterone. In this blog, we’ll delve into the nuanced landscape of MHT, exploring advantages, associated risks, and the populations of women who might benefit from it.
Although less common than the baby blues, PMADs also affect a great number of new parents: 1 in 5 women, or 20%, are affected. More traditionally termed “Postpartum Depression,” it is important to recognize that PMADs actually encompass a variety of mental health conditions including depression, anxiety, obsessive-compulsive disorder (OCD), bipolar mood disorder, and postpartum psychosis.
Many parents have heard the term Postpartum Depression, but PERINATAL encompasses both the pregnancy and postpartum periods, extending to 1 year AFTER delivery. While mild mood changes can be common during the perinatal period, up to 1 IN 5 women (20%) experience more significant perinatal mood and anxiety disorders – also known as PMADs. PMADs can affect anyone and do not discriminate based on ethnicity, age or socioeconomic status. Here, we’ll discuss the implications of PMADs during pregnancy, symptoms to look out for, and what you can do to reduce your pregnancy-related risks and to feel better.